Kati Dessauer
Family Medicine · Cary, NCNPI 1306832563
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,014 and has fallen 89.4% since, to $107 in 2023.
Across 212 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$639
- Novo Nordisk$530
- AstraZeneca$331
- Amarin Pharma, Inc.$201
- Amgen$196
- GSK$175
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,24999%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $639 |
| Novo Nordisk | 39 | $530 |
| AstraZeneca | 22 | $331 |
| Amarin Pharma, Inc. | 13 | $201 |
| Amgen | 16 | $196 |
| GSK | 11 | $175 |
| Astellas Pharma US Inc | 11 | $174 |
| Lilly USA, LLC | 9 | $143 |
| Boehringer Ingelheim | 7 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $126 |
| Pfizer | 7 | $90 |
| Eisai Inc. | 4 | $80 |
| Abbott | 3 | $71 |
| Radius Health, Inc. | 3 | $60 |
| Merck | 4 | $51 |
| Johnson & Johnson | 3 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Therapeuticsmd, Inc. | 2 | $23 |
| Bayer | 1 | $20 |
| IBSA Pharma Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Medicure Pharma Inc. | 1 | $12 |
How this compares
$3,276 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Cary
- Christopher ChaoCary$201K
- Charlie FosterCary$23K
- Jing ZhangCary$23K
- David AdamsCary$20K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.